Live stream preview
OS Therapies CEO on clinical advancements in immunotherapy for osteosarcoma
Floor Talk
•
4m 43s
Paul Romness, CEO of OS Therapies, tells us about the company’s progress since its August 2024 IPO and its latest clinical advancements in immunotherapy for osteosarcoma and other solid tumors on #NYSEFloorTalk with Judy Shaw.
Up Next in Floor Talk
-
Aimeé Lapic, CEO of Hanna Andersson, ...
Aimeé Lapic, CEO of Hanna Andersson, joins Ashley Mastronardi on NYSE Floor Talk from ICR
-
CoachHub CEO on making coaching more ...
Matti Niebelschütz, CEO & Co-Founder of CoachHub, discusses the future of coaching in the ‘people era,’ how AI is making coaching more accessible, and the role of AIMY™ AI Coach in transforming workplace learning on #NYSEFloorTalk with Judy Shaw.
-
Barry McGowan, CEO of Fogo de Chao, J...
Barry McGowan, CEO of Fogo de Chao, joins Ashley Mastronardi on NYSE Floor Talk from ICR
